To Continue or Interrupt DOAC Therapy? The Evidence Remains Unclear – RPTH Journal
RPTH Journal shared on LinkedIn about a recent article by Alexander Xiang et al, adding:
”For patients undergoing minimal bleeding-risk procedures, this systematic review and meta-analysis suggests the answer may not be so straightforward.
In a new RPTH Journal State of the Art review, across 24 studies involving 8,663 patients, continuous DOAC therapy was associated with fewer thrombotic and major bleeding events in the overall analysis.
However, when the authors focused on the highest-quality randomized trials, those apparent benefits disappeared, showing no significant differences in thrombotic events, major bleeding, minor bleeding, complications, or mortality between continuing and interrupting DOAC therapy.
The take-home message?
Current evidence suggests that either strategy appears acceptable for minimal bleeding-risk procedures, but better randomized studies are still needed to define the optimal approach.”
Title: Continuous vs interrupted direct oral anticoagulants for minimal bleeding-risk surgical procedures—a systematic review and meta-analysis
Authors: Alexander Xiang, Shakil Popatia, Sarah Lopes Sadafi, Megha Rao, Asim Shaikh, Mehrad Nowrouzi, Allen Li, Ali Eshaghpour, Mark Crowther

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 13, 2026, 03:21Abdul Muqtadir Abbasi: Iron Deficiency Beyond Anemia and the Importance of Finding the Cause
-
Nov 13, 2026, 03:05Marc Carrier: Aspirin vs Anticoagulants for VTE Prevention After Joint Replacement
-
Nov 13, 2026, 02:28Julia Sjöberg: ROCK1 Inhibition and Red Blood Cell Recovery After Chemotherapy
-
Nov 13, 2026, 02:07Tonie Reincke: Understanding Deep Vein Thrombosis and Vascular Health
-
Nov 13, 2026, 01:52Akshita Singh: The Remarkable Process of Blood Clotting
-
Nov 12, 2026, 22:52Milka Koupenova: The Role of Platelet RIG-I in Regulating Thrombotic Responses
-
Nov 12, 2026, 22:50Arun V J: Why Has India Still Not Achieved 100% Voluntary Blood Donation?
-
Nov 12, 2026, 22:49Sickle Cell Disease Deserves to Be Prioritised in Ghana – ISCC
-
Nov 12, 2026, 22:47Samir Kumar Beura: Delighted to Serve as a Topic Editor for a Research Topic in Frontiers in Neuroscience